CRBP Corbus Pharmaceuticals Holdings4.37-0.04 (-0.9%)
CRBP Corbus Pharmaceuticals Holdings5.32+0.05 (+1.0%)
CRBP Corbus Pharmaceuticals Holdings6.66-1.42 (-17.6%)
CRBP Corbus Pharmaceuticals Holdings8.27+0.15 (+1.9%)
After Hours Gainer
CRBP Corbus Pharmaceuticals Holdings8.12-0.12-1.5%
After Hours:10.44+2.32 (+28.6%)
Corbus Pharmaceuticals to Host Conference Call to Discuss Topline Data from CANYON-1 Clinical Trial and the Potential of CRB-913 In Obesity
Globe NewswireFri, 11-Sep 4:01 PM